Lineage Cell Therapeutics, Inc. Preferred Stock, Shares Outstanding
Lineage Cell Therapeutics, Inc. (LCTX) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-07 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-06 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-11 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 0.00 shares 10-Q · filed 2017-11-09 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-04 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-16 |
| 2015-09-30 | 70.00K shares 10-Q · filed 2015-11-09 |
| 2015-06-30 | 70.00K shares 10-Q · filed 2015-08-10 |
| 2015-03-31 | 70.00K shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 70.00K shares 10-K · filed 2016-03-15 |
| 2014-09-30 | 70.00K shares 10-Q · filed 2014-11-07 |
| 2014-06-30 | 70.00K shares 10-Q · filed 2014-08-11 |
| 2014-03-31 | 70.00K shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-11 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-17 |
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-09 |
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-09 |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |